ReviewCritical care (London, England)2018

Inhaled amikacin for severe Gram-negative pulmonary infections in the intensive care unit: current status and future prospects.

Antoni Torres et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.